Successful treatment of moderate-to-severe alopecia areata improves health-related quality of life

J Am Acad Dermatol. 2018 Mar;78(3):597-599.e2. doi: 10.1016/j.jaad.2017.10.046. Epub 2017 Nov 8.

Authors

Lucy Y Liu¹, Brittany G Craiglow², Brett A King³

Affiliations

¹ Yale University School of Medicine, New Haven, Connecticut.
² Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
³ Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut. Electronic address: brett.king@yale.edu.

PMID: 29128459
DOI: 10.1016/j.jaad.2017.10.046

No abstract available

Publication types

Letter

MeSH terms

Adult
Alopecia Areata / drug therapy*
Alopecia Areata / psychology*
Emotions
Female
Humans
Male
Middle Aged
Piperidines / therapeutic use
Protein Kinase Inhibitors / therapeutic use
Pyrimidines / therapeutic use
Pyrroles / therapeutic use
Quality of Life / psychology*
Severity of Illness Index
Surveys and Questionnaires
Young Adult

Substances

Piperidines
Protein Kinase Inhibitors
Pyrimidines
Pyrroles
tofacitinib